AlQa'dah 09, 1435, September 04, 2014, SPA -- NewLink Genetics Corp said the U.S. Food and Drug Administration allowed the company to start testing an experimental Ebola vaccine in humans, Reuters reported. The vaccine, developed by Canadian government scientists, has been licensed to the company.